Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apellis Pharmaceuticals (APLS) Change in Cash (2020 - 2025)

Apellis Pharmaceuticals filings provide 6 years of Change in Cash readings, the most recent being -$12.8 million for Q4 2025.

  • For the quarter ending Q4 2025, Change in Cash fell 189.33% year-over-year to -$12.8 million, compared with a TTM value of $55.1 million through Dec 2025, down 8.56%, and an annual FY2025 reading of $55.1 million, down 8.56% over the prior year.
  • Change in Cash hit -$12.8 million in Q4 2025 for Apellis Pharmaceuticals, down from $109.1 million in the prior quarter.
  • The five-year high for Change in Cash was $356.4 million in Q4 2021, with the low at -$300.1 million in Q1 2021.
  • Median Change in Cash over the past 5 years was -$9.8 million (2022), compared with a mean of -$5.0 million.
  • The largest YoY upside for Change in Cash was 3263.97% in 2023 against a maximum downside of 706.84% in 2023.
  • Year by year, Change in Cash stood at $356.4 million in 2021, then crashed by 109.08% to -$32.4 million in 2022, then crashed by 212.6% to -$101.2 million in 2023, then soared by 114.2% to $14.4 million in 2024, then tumbled by 189.33% to -$12.8 million in 2025.
  • According to Business Quant data, Change in Cash over the past three periods came in at -$12.8 million, $109.1 million, and $11.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.